A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, Cui Y, Siederer S, Parry S, Kenny J, Slack RJ, Sahota J, Paul L, Saunders P, Molyneaux PL, Lukey PT, Rizzo G, Searle GE, Marshall RP, Saleem A, Kang'ombe AR, Fairman D, Fahy WA, Vahdati-Bolouri M.
Maher TM, et al. Among authors: siederer s.
Respir Res. 2020 Mar 26;21(1):75. doi: 10.1186/s12931-020-01339-7.
Respir Res. 2020.
PMID: 32216814
Free PMC article.
Clinical Trial.